Frailty-focused prehabilitation enters the elective TAVR pathway

Older adults with frailty face a very different risk profile when they are being prepared for transcatheter aortic valve replacement. The BMJ Open protocol centers on that problem directly: can a nurse-coordinated multidisciplinary prehabilitation approach improve readiness for elective TAVR in this vulnerable population?

The study is designed as a randomised controlled trial, and its value begins before any outcome data are available. Prehabilitation has become a practical concept in procedural medicine because frailty is not a static label; it often reflects modifiable deficits in strength, mobility, nutrition, and overall physiologic reserve. In the setting of TAVR, those deficits can shape whether a patient tolerates the procedure well, mobilises afterward, and returns to baseline function without a prolonged recovery.

Elective TAVR has transformed care for aortic stenosis, especially in older adults who are poor candidates for open surgery. Yet age alone is not the issue. Frailty changes the equation by compressing physiologic reserve, making even a technically successful valve intervention vulnerable to downstream setbacks such as slow rehabilitation, persistent dependency, and limited functional gain. A prehabilitation model aims to address those risks before the catheter-based procedure rather than waiting to react after them emerge.

Why frailty matters before valve replacement

Frailty sits at the center of this protocol because it captures more than comorbidity burden. It reflects the cumulative effect of diminished physical reserve, impaired resilience, and reduced capacity to recover from stress. For patients facing elective TAVR, that matters at bedside level: the same procedure can produce very different trajectories depending on baseline muscle function, nutritional status, symptom burden, and support needs.

A nurse-coordinated multidisciplinary structure is a logical fit for this population. Older adults preparing for TAVR often require more than a single intervention. They may need exercise guidance, medication review, nutritional support, symptom surveillance, and practical coordination across disciplines. Nursing leadership can knit those elements together into a single care pathway, which is especially important when patients are frail and are less likely to navigate fragmented preparation well on their own.

The protocol’s focus on older adults with frailty also reflects a broader procedural shift. Structural heart interventions are increasingly offered to patients who would previously have been considered too high risk for surgery, but “high risk” is not a uniform category. Some patients are limited mainly by valve obstruction; others have a heavy burden of geriatric vulnerability that may blunt the gains of intervention. Prehabilitation is designed to reduce that mismatch between procedural success and patient-centered recovery.

Multidisciplinary preparation as a clinical strategy

In this trial, the term multidisciplinary carries real clinical weight. It implies that the preoperative period is being treated as a therapeutic window rather than a passive waiting period. For frail older adults, that window can be used to improve physical readiness, reinforce self-management, and coordinate services that may influence recovery after valve implantation.

A nurse-coordinated model is especially relevant because nurses often sit closest to the daily realities of symptom burden, mobility limitations, and adherence barriers. They can identify deterioration early, align the patient with the appropriate members of the care team, and maintain continuity across the preprocedural period. In frail patients, continuity is not a soft variable; it can determine whether optimization efforts actually happen before the intervention date.

The biological logic is straightforward. A frail patient entering TAVR with better functional reserve is more likely to tolerate vascular access, procedural stress, anesthesia-related effects, and the immediate postprocedure recovery period. Even modest gains in strength or nutrition may influence whether a patient can walk sooner, participate in rehabilitation, and avoid the spiral of immobility that often follows hospitalization in older adults.

What a protocol can and cannot claim

This publication is a trial protocol, not a results paper. It establishes the clinical question, the target population, and the randomized design, but it does not yet provide outcome data. That matters because protocol papers should be judged on whether they set up a meaningful test of a plausible intervention rather than on efficacy claims they have not earned.

The decision to publish a protocol is itself useful to clinicians. It signals that investigators see enough uncertainty in current practice to justify formal testing of prehabilitation before elective TAVR. In geriatric procedural care, that uncertainty is familiar: many programs recognize frailty, but not every center has a structured pathway to optimize it before intervention. A randomized trial can move the discussion from intuition to evidence.

There is also a wider systems implication. If a nurse-coordinated multidisciplinary approach proves workable, it could offer a reproducible model for centers that perform TAVR but do not yet have integrated prehabilitation services. If it proves difficult to implement, that too would be clinically informative, because frail patients often need interventions that are realistic in busy cardiovascular programs rather than idealized but impractical protocols.

The clinical question remains tightly framed

This trial is not asking whether TAVR works; that question is already answered for many patients with severe aortic stenosis. It is asking whether the pathway leading into TAVR can be improved for older adults with frailty through structured, nurse-led multidisciplinary preparation. The distinction is narrow, but it is important at the bedside, where recovery depends on more than valve deployment alone.

The protocol leaves several practical questions for the eventual trial readout: whether the intervention can be delivered consistently, whether frail patients will engage with it, and whether the model can alter recovery in a way that matters to patients and clinicians. Until those data arrive, the study stands as a careful attempt to bring geriatric optimization into structural heart care rather than a claim of benefit already proven.


Reporting by Dr. Aishwarya N., MBBS for Medicine World Foundation, with additional data provided by BMJ Open.